A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study
Open Access
- 17 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 52 (7), 1202-1207
- https://doi.org/10.1093/rheumatology/kes362
Abstract
Objective. To evaluate a multi-biomarker disease activity (MBDA) score, a novel index based on 12 serum proteins, as a tool to guide management of RA patients. Methods. A total of 125 patients with RA from the Behandel Strategieën study were studied. Clinical data and serum samples were available from 179 visits, 91 at baseline and 88 at year 1. In each serum sample, 12 biomarkers were measured by quantitative multiplex immunoassays and the concentrations were used as input to a pre-specified algorithm to calculate MBDA scores. Results. MBDA scores had significant correlation with DAS28-ESR (Spearman’s ρ = 0.66, P < 0.0001) and also correlated with simplified disease activity index, clinical disease activity index and HAQ Disability Index (all P < 0.0001). Changes in MBDA between baseline and year 1 were also correlated with changes in DAS28-ESR (ρ = 0.55, P < 0.0001). Groups stratified by European League Against Rheumatism disease activity (DAS28-ESR ≤ 3.2, 3.2–5.1 and > 5.1) had significantly different MBDA scores (P < 0.0001) and MBDA score could discriminate ACR/EULAR Boolean remission with an area under the receiver operating characteristic curve of 0.83 (P < 0.0001). Conclusion: The MBDA score reflects current clinical disease activity and can track changes in disease activity over time.Keywords
This publication has 20 references indexed in Scilit:
- Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activityArthritis Care & Research, 2012
- Efficient management of rheumatoid arthritis significantly reduces long-term functional disabilityAnnals Of The Rheumatic Diseases, 2008
- Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)Annals Of The Rheumatic Diseases, 2007
- Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold valuesAnnals Of The Rheumatic Diseases, 2007
- Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trialsNature Clinical Practice Rheumatology, 2006
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trialArthritis & Rheumatism, 2005
- The DAS28 in rheumatoid arthritis and fibromyalgia patientsRheumatology, 2004
- Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trialThe Lancet, 2004
- A simplified disease activity index for rheumatoid arthritis for use in clinical practiceRheumatology, 2003
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988